Basilea Pharmaceutica Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3
Founded: Basel Switzerland (2000)

Organization Overview

First Clinical Trial
2004
NCT00228982
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Basilea Pharmaceutica | Basilea Pharmaceutica International Ltd